5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving...

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Acetylcholine (ACh) plays a crucial role in cognitive functions and is modulated by various neurotransmitter systems.
• Serotonin (5-hydroxytryptamine, 5-HT) is implicated in regulating cortical activity, but its precise influence on ACh release is not fully understood.

Purpose of the Study:

• To investigate the role of specific serotonin receptor subtypes (5-HT1A, 5-HT2, and 5-HT3) in modulating acetylcholine release in the guinea-pig cerebral cortex.
• To differentiate between direct and indirect effects of serotonin on cholinergic neurons.

Main Methods:

• In vivo studies in freely moving guinea-pigs measuring cortical ACh release.
• Administration of selective 5-HT receptor agonists and antagonists.
• In vitro studies using cerebral cortex slices to assess [3H]-choline efflux.

Main Results:

• 5-HT1A receptor agonists (8-OH-DPAT, Ru 24969) dose-dependently increased ACh release, an effect blocked by 5-HT1A antagonists ((-)-propranolol, metitepine).
• 5-HT3 receptor agonists (2-Methyl-5-HT, 5-HT) inhibited ACh release, an effect prevented by the 5-HT3 antagonist (ICS 205-930).
• 5-HT2 receptor agonists (DOI) and antagonists (ketanserin) did not affect ACh release, and direct application of agonists to cortical slices did not alter [3H]-choline efflux.

Conclusions:

• Exogenous serotonin and its selective agonists modulate cortical cholinergic neurotransmission primarily through 5-HT1A and 5-HT3 receptors.
• 5-HT1A receptor stimulation may disinhibit cholinergic neurons, while 5-HT3 receptor activation inhibits ACh release, likely via interneurons.
• These findings suggest indirect modulation of cholinergic nerve endings by serotonin, rather than direct interaction.